The Patent Finder

Aurobac Therapeutics SAS

Also on record
Records under this name other than the patents Aurobac Therapeutics SAS holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 3 patents it holds.

Showing 1 to 3 of 3 · Back to Aurobac Therapeutics SAS

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 11,524,046Biofilm Prevention, Disruption and Treatment with Bacteriophage Lysin
Formerly held
In force
 · Medium confidence
In forceMedium confidence
US 11,413,334Lysin Polypeptides Active Against Gram-Negative Bacteria
Lapsed on the fee record
Ended Aug 16, 2026 · High confidence
Lapsed on the fee recordEnded Aug 16, 2026High confidence
US 9,889,181Bacteriophage Lysin and Antibiotic Combinations Against Gram Positive Bacteria
Formerly held
Lapsed on the fee record
Ended Feb 13, 2026 · Low confidence
Lapsed on the fee recordEnded Feb 13, 2026Low confidence
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited